Case number 1:22-cv-01596
Bayer Pharma AG et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Jun 20, 2023 | 19 | SO ORDERED Granting (D.I. 154 in 21-md-3017-RGA; D.I. 17 in 22-cv-1596-RGA) Stipulation and Order Regarding Infringement. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms) (Entered: 06/20/2023) (3) |
| Jun 20, 2023 | 20 | SO ORDERED Granting (D.I. 155 in 21-md-3017-RGA; D.I. 146 in 21-cv-314-RGA-JLH; D.I. 18 in 22-cv-1596-RGA) Stipulation and Order Regarding Consolidation and Scheduled. Signed by Judge Richard G. Andrews on 6/20/2023. Associated Cases: 1:21-md-03017-RGA, 1:21-cv-00314-RGA-JLH, 1:22-cv-01596-RGA(nms) (Entered: 06/20/2023) (5) |
| Jun 2, 2023 | 17 | STIPULATION and Order Regarding Infringement, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms). (Entered: 06/02/2023) (3) |
| Jun 2, 2023 | 18 | STIPULATION and Order Regarding Consolidation and Schedule, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 6/5/2023 (nms). (Entered: 06/02/2023) (5) |
| Mar 24, 2023 | 16 | ANSWER to 11 Answer to Complaint, and Counterclaims, by Bayer AG, Bayer Pharma AG, Janssen Pharmaceuticals, Inc..(Blumenfeld, Jack) Modified on 3/24/2023 (nms). (Entered: 03/24/2023) (9) |
| Mar 8, 2023 | 15 | NOTICE OF SERVICE of (1) Apotex's ANDA Production and (2) Apotex's Core Technical Documents Production filed by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) (Entered: 03/08/2023) (2) |
| Mar 7, 2023 | N/A | CORRECTING ENTRY: The Answer (D.I. 11), 7.1 Disclosure Statements (D.I. 12; D.I. 13), and Motion for Pro Hac (D.I. 14) filed on 3/6/2023, have all been removed from the docket. Upon review it was determined this case is a member to MDL 21-3017-RGA. All filings need to bear a dual caption to the MDL case as well as the underlying civil action and be filed accordingly. Defendants are requested to amend and resubmit the filings. (nms) (Entered: 03/07/2023) (0) |
| Mar 7, 2023 | 11 | ANSWER to 1 Complaint and COUNTERCLAIMS against all Plaintiffs, by Apotex Corp., Apotex Inc..(Dorsney, Kenneth) Modified on 3/8/2023 (nms). (Entered: 03/07/2023) (22) |
| Mar 7, 2023 | 12 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceuticals Holdings, Inc. for Apotex Inc. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/07/2023) (2) |
| Mar 7, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/07/2023) (2) |
| Mar 7, 2023 | 14 | MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 03/07/2023) (4) |
| Mar 7, 2023 | N/A | SO ORDERED, re (D.I. 14 in 22-cv-1596-RGA; D.I. 145 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 3/7/2023. Associated Cases: 1:21-md-03017-RGA, 1:22-cv-01596-RGA(nms) (Entered: 03/07/2023) (0) |
| Mar 7, 2023 | N/A | Pro Hac Vice Attorney Brian Sodikoff and Rachel L. Schweers for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 03/07/2023) (0) |
| Jan 27, 2023 | 9 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Apotex Corp. waiver sent on 1/3/2023, answer due 3/6/2023. (Fahnestock, Derek) (Entered: 01/27/2023) (1) |
| Jan 27, 2023 | 10 | WAIVER OF SERVICE returned executed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG: For Apotex Inc. waiver sent on 1/3/2023, answer due 3/6/2023. (Fahnestock, Derek) (Entered: 01/27/2023) (1) |
| Dec 21, 2022 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) (Entered: 12/21/2022) (0) |
| Dec 14, 2022 | 1 | COMPLAINT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 402, receipt number ADEDC-4025950.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(lam) (Entered: 12/14/2022) (Main Document) (13) |
| Dec 14, 2022 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (lam) (Entered: 12/14/2022) (3) |
| Dec 14, 2022 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: Not earlier than 11/01/22. Date of Expiration of Patent: U.S. Patent 10,828,310 expires January 31, 2039, with pediatric exclusivity to July 31, 2039..Thirty Month Stay Deadline: 5/1/2025. (lam) (Entered: 12/14/2022) (1) |
| Dec 14, 2022 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 10,828,310 B2. (lam) (Entered: 12/14/2022) (1) |
| Dec 14, 2022 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Pharma AG filed by Bayer Pharma AG. (lam) (Entered: 12/14/2022) (1) |
| Dec 14, 2022 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc.. (lam) (Entered: 12/14/2022) (1) |
| Dec 14, 2022 | 7 | Summons Issued as to Apotex Corp. on 12/14/2022. (lam) (Entered: 12/14/2022) (2) |
| Dec 14, 2022 | 8 | Summons Issued as to Apotex Inc. on 12/14/2022. (lam) (Entered: 12/15/2022) (2) |
| Dec 14, 2022 | 1 | COMPLAINT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 402, receipt number ADEDC-4025950.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(lam) (Entered: 12/14/2022) (Exhibit A) (27) |
| Dec 14, 2022 | 1 | COMPLAINT filed against Apotex Corp., Apotex Inc. ( Filing fee $ 402, receipt number ADEDC-4025950.) - filed by Bayer Pharma AG, Janssen Pharmaceuticals, Inc., Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(lam) (Entered: 12/14/2022) (Civil Cover Sheet) (2) |
